The Fundamentals of Pulmonary Hypertension for Advanced Allied Health Professionals, in its final course, uses the knowledge from the basics and diagnostics courses to discuss test result integration and application to patient care. This course provides a high-quality, in-depth understanding of risk stratification and how to communicate results and risks to patients with pulmonary hypertension. The course provides you with experiences in test interpretation and dynamics of patient communication with experts from nationally recognized pulmonary hypertension clinics, enabling you to understand test results and the application of these results in patient care.
Integrating Test Results and the Importance of Patient Communication
4
episodes
1.00 program credits 59m
Details
Presenters
Comments
Target Audience
This activity has been designed to meet the educational needs of Pulmonologists and Cardiologists, as well as Primary Care Physicians, Physicians Assistants, Nurse Practitioners, Nurses, Pharmacists, and all other healthcare providers who are involved in the management of patients with pulmonary hypertension.
Learning Objectives
After participating in this educational activity, participants should be better able to:
- Classify patients into appropriate categories for timely management.
- Appraise findings from diagnostic testing for risk stratification and appropriate interdisciplinary referrals in patients with pulmonary hypertension.
- Discuss dynamics of patient communication in patients with pulmonary hypertension with varying risk levels.
Accreditation and Credit Designation Statements
In support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and Total CME, LLC. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the American Nurses Credentialing Center (ANCC) and the Accreditation Council for Pharmacy Education (ACPE) to provide continuing education for the healthcare team.Global Learning Collaborative (GLC) designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 1.0 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 1.0 CEUs of pharmacy contact hours. The Universal Activity Number for this program is JA0006235-0000-24-021-H01-P. This learning activity is knowledge based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service at custserv@napb.net.
Disclosure of Conflicts of Interest
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
The following faculty have reported relationships with ineligible companies:
Martha Kingman, DNP, FNP-C, chair for this educational event, has received consulting fees from Janssen, Liquidia, Aerovate, Aerami, Merck, and Gossamer Bio.
Susanne McDevitt, DNP, ACNP-BC, faculty for this educational event, has received consulting fees from Janssen, Liquidia, Merck, Gossamer Bio, United Therapeutics, and Aerami; and received research grants from Janssen, Aerovate, Merck, and Gossamer Bio.
Planners and Managers Disclosure List
The following planners/reviewers/managers have disclosed:
Prerna Poojary, PhD, planner for this educational event, has no relevant financial relationships with ineligible companies.
William Mencia, MD, FACEHP, CHCP, reviewer for this educational event, has no relevant financial relationships with ineligible companies.
Total CME, LLC., planners and managers have no relevant commercial relationships to disclose.
All the relevant financial relationships for these individuals have been mitigated.
Provider(s)/Educational Partner(s)
Jointly provided by Global Learning Collaborative (GLC) and Total CME, LLC.
Commercial Support
This activity is supported by an independent educational grant from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Total CME, Inc. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Medical Masterclass you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
